MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,014,000 | -30.2% | 3,888,656 | 0.0% | 0.00% | – |
| Q2 2020 | $4,316,000 | +148.8% | 3,888,656 | 0.0% | 0.00% | – |
| Q1 2020 | $1,735,000 | +25.2% | 3,888,656 | +34.6% | 0.00% | – |
| Q4 2019 | $1,386,000 | -34.4% | 2,888,656 | 0.0% | 0.00% | – |
| Q3 2019 | $2,112,000 | -64.3% | 2,888,656 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $5,922,000 | -26.5% | 2,888,656 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,059,000 | -7.9% | 2,888,656 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $8,753,000 | -59.1% | 2,888,656 | -24.7% | 0.00% | -50.0% |
| Q3 2018 | $21,417,000 | -22.9% | 3,838,086 | -11.4% | 0.00% | -33.3% |
| Q2 2018 | $27,774,000 | -8.6% | 4,332,888 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $30,374,000 | -6.8% | 4,332,888 | +38.7% | 0.00% | 0.0% |
| Q4 2017 | $32,593,000 | +14.0% | 3,124,888 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $28,593,000 | -29.2% | 3,124,888 | 0.0% | 0.00% | -40.0% |
| Q2 2017 | $40,405,000 | +3.9% | 3,124,888 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $38,874,000 | – | 3,124,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 92,200 | $646,000 | 0.88% |
| 683 Capital Management, LLC | 500,000 | $3,505,000 | 0.31% |
| BIEGEL & WALLER LLC | 66,508 | $466,000 | 0.30% |
| Monashee Investment Management LLC | 94,000 | $659,000 | 0.18% |
| Aveo Capital Partners, LLC | 16,732 | $117,000 | 0.05% |
| Artal Group S.A. | 500,000 | $3,505,000 | 0.04% |
| Radnor Capital Management, LLC | 10,000 | $70,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 12,672 | $89,000 | 0.01% |
| Trexquant Investment LP | 15,757 | $110,000 | 0.01% |
| FMR LLC | 4,332,888 | $30,374,000 | 0.00% |